Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 181,095 | 193,705 | 224,947 | 226,672 | 106,773 |
| Marketable Securities | 142,485 | 104,819 | 2,495 | 20,213 | 71,455 |
| Receivables | 30,841 | 31,361 | 17,714 | 6,370 | 246 |
| Inventories | 2,195 | 4,036 | 3,107 | 15 | N/A |
| TOTAL | $362,588 | $340,724 | $256,131 | $259,277 | $183,476 |
| Non-Current Assets | |||||
| PPE Net | 2,241 | 1,338 | 1,468 | 1,614 | 1,541 |
| Investments And Advances | 3,000 | 0 | 631 | 210 | 322 |
| Intangibles | 3,667 | 3,767 | 3,867 | 3,967 | 0 |
| Other Non-Current Assets | 5,348 | 3,449 | 3,394 | 3,264 | 3,588 |
| TOTAL | $14,256 | $8,554 | $9,360 | $9,055 | $5,451 |
| Total Assets | $376,844 | $349,278 | $265,491 | $268,332 | $188,927 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 43,526 | 36,570 | 23,691 | 15,351 | 9,459 |
| TOTAL | $51,571 | $42,528 | $36,936 | $23,249 | $14,765 |
| Non-Current Liabilities | |||||
| Long Term Debt | 71,578 | 29,933 | 29,819 | 29,708 | 24,607 |
| Other Non-Current Liabilities | 1,449 | 1,606 | 1,748 | 1,711 | 1,826 |
| TOTAL | $73,027 | $31,539 | $31,567 | $31,419 | $26,433 |
| Total Liabilities | $124,598 | $74,067 | $68,503 | $54,668 | $41,198 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,042 | 37,782 | 34,219 | 33,105 | 32,617 |
| Common Shares | 6 | 6 | 5 | 5 | 5 |
| Retained earnings | -313,677 | -280,387 | -244,656 | -202,754 | -163,606 |
| Other shareholders' equity | -176 | -63 | -2 | -8 | -23 |
| TOTAL | $252,246 | $275,211 | $196,988 | $213,664 | $147,729 |
| Total Liabilities And Equity | $376,844 | $349,278 | $265,491 | $268,332 | $188,927 |